Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus.
about
The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genesTranscription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stagesInhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodiesNovel mechanism and factor for regulation by HIV-1 TatRelatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufenLa autoantigen alleviates translational repression by the 5' leader sequence of the human immunodeficiency virus type 1 mRNARegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsFunctional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeatInteractions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivatorTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationThe apical loop of the HIV-1 TAR RNA hairpin is stabilized by a cross-loop base pairCell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335Phosphorylation and binding of AUF1 to the 3'-untranslated region of cardiomyocyte SERCA2a mRNAAptamers: the emerging class of future anticoagulation for vascular disease.Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.Gene therapy for infectious diseasesA nuclear matrix-specific factor that binds a specific segment of the negative regulatory element (NRE) of HIV-1 LTR and inhibits NF-kappa(B) activityQuantification of DNA-protein interaction by UV crosslinkingIn vivo selection of randomly mutated retroviral genomes.Viral-host interactions that control HIV-1 transcriptional elongationInduction of RNA-binding proteins in mammalian cells by DNA-damaging agents.Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription.Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe.Peptide models of the Tat-TAR protein-RNA interactionMechanism of action of regulatory proteins encoded by complex retrovirusesDetailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains.An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy.Interaction of nuclear protein p140 with human immunodeficiency virus type 1 TAR RNA in mitogen-activated primary human T lymphocytes.CAG trinucleotide RNA repeats interact with RNA-binding proteins.Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivationHIV-1 Tat protein promotes formation of more-processive elongation complexes.Human immunodeficiency virus type 1 transactivator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro.Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells.Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequencesEffects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides.Direct interactions between autoantigen La and human immunodeficiency virus leader RNA.Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat proteinThe full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression.The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase
P2860
Q24319734-3C07E6C6-A317-425C-9CA0-DEE8F2A457EAQ24533266-949C26C1-4F2B-4029-AE94-CAF907A2C959Q24568329-696668E5-057F-4FD0-9575-F9197641FD1EQ24568366-A65392B6-48F9-4955-BE4E-E8542F74BC5AQ24606166-994ED364-857B-48B8-A1CD-01F110A49FC3Q24645620-DFF0D65E-459F-4871-AA0C-8FD8DD3E217DQ24651506-167096AC-B658-4DAC-A355-3A377D8F16DEQ24655684-DB580F47-60B7-43B1-8A91-BFD9F47402A6Q24671522-858F9FD2-42E1-4B40-A53B-22DEF84A1B51Q24681560-0D9B868F-7529-4915-A4BF-3EECCCA58085Q28189849-9ECE6FFB-F45F-4152-A259-1A2374D77E3FQ28342742-53454AA6-CE2D-494E-8745-70DEF74CFD03Q28574911-74D45B39-E09F-4D1C-9AD9-29E304D4C94AQ33389174-7BB99BCB-8BBA-4D9C-AF70-A46257A114ACQ33900660-3A14E52E-7142-4EA8-A133-D5CAFF85D9ADQ33992464-0D1BB5F3-D1AD-4758-AE90-30B39609A579Q34597244-74713F39-C65A-48F3-8EE1-1FC7AB543E61Q34768506-BF7B26B8-AA67-4307-8DC5-6ED42C9A6C29Q35019436-78F4C128-4F00-4DB5-A403-C46A1FC5AC3DQ35026881-9C59FAC4-8745-41FD-B181-7813A0ED02B1Q35057947-64A69486-1CC0-42C8-B4F7-9CF01A1672F8Q35059684-4F4E4F6F-FB94-41EC-ACD6-A9FA40D5DF25Q35070466-B8806CED-B0F7-44F9-8EFE-81B47E46BE89Q35222971-2A082FDE-5BB3-41BE-B428-4789C393C4CAQ35403061-6F4401FA-0FFF-48F2-9958-C1195AE07936Q35792991-BE02D791-BC96-4CE6-ACE5-65F031C72895Q35829302-62627768-0013-4C70-AA49-B32F10D0B1BDQ35845299-E78EE064-ECD3-4B8D-990E-7F1BA29D46DAQ35882320-B0228513-8355-45BE-8AC3-E9E6AB4B079CQ35928622-98470628-02E2-4F81-BF7B-94B97313E895Q35937536-F83C0F04-84E9-4CAB-89C9-EDB0482824FFQ36398874-A5ECAD06-D332-4829-AEAA-5858F110782BQ36481470-8793EB3B-D24A-4B2E-A113-971FE827F28EQ36618678-FFCE1CB6-BB15-44AE-A3F6-CB07E3D448DEQ36633736-22D14F6D-508A-4398-9F5A-3DBD63D760C7Q36636851-A797B1FD-D0BC-4DAD-B495-93FA0D208779Q36638137-2A1E5703-7084-463B-B9A8-BA60A00B1A89Q36639281-1E64D668-80BA-41C5-9452-065147110AC6Q36649447-50E6AF6E-90C0-445C-A600-F92379334FC6Q36679792-D58E4F61-43EB-44D6-8F7E-563DCF2AE06C
P2860
Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Identification and characteriz ...... human immunodeficiency virus.
@ast
Identification and characteriz ...... human immunodeficiency virus.
@en
Identification and characteriz ...... the trans-activation-response
@nl
type
label
Identification and characteriz ...... human immunodeficiency virus.
@ast
Identification and characteriz ...... human immunodeficiency virus.
@en
Identification and characteriz ...... the trans-activation-response
@nl
prefLabel
Identification and characteriz ...... human immunodeficiency virus.
@ast
Identification and characteriz ...... human immunodeficiency virus.
@en
Identification and characteriz ...... the trans-activation-response
@nl
P2093
P2860
P356
P1476
Identification and characteriz ...... human immunodeficiency virus.
@en
P2093
Garcia-Blanco MA
Marciniak RA
P2860
P304
P356
10.1073/PNAS.87.9.3624
P407
P577
1990-05-01T00:00:00Z